[Neonatal Hypoglycemia: Review of usual practices]

Area of Science:

• Neonatal Medicine
• Pediatric Neurology

Background:

• Hypoglycemia poses a risk of long-term neurological damage in newborns.
• Current guidelines lack consensus on safe blood glucose limits for neonates.
• Management of neonatal hypoglycemia remains a controversial issue.

Purpose of the Study:

• To unify management and care criteria for newborns experiencing hypoglycemia.
• To clarify which infants require blood glucose evaluation in early life.
• To provide evidence-based recommendations for neonatal glucose monitoring.

Main Methods:

• Review of current literature and clinical practices regarding neonatal hypoglycemia.
• Consensus development by the Committee on Fetal-Neonatal Studies (CEFEN) and neonatologists.
• Analysis of evidence for routine versus risk-stratified glucose screening.

Main Results:

• Routine blood glucose detection in healthy term infants is not supported by evidence.
• Glucose evaluation should be reserved for high-risk newborns.
• Identification of specific risk factors necessitating neonatal glucose monitoring.

Conclusions:

• Establishing clear criteria for neonatal hypoglycemia evaluation is crucial.
• Risk-stratified screening improves resource allocation and clinical focus.
• Evidence-based guidelines are needed to standardize care for neonatal hypoglycemia.